References
- Takatsu T, Tagaya I, Hirayama M. Poliomyelitis in Japan during the period 1962–68 after the introduction of mass vaccination with Sabin vaccine. Bulletin WHO 1973; 49: 129–37
- Shimojo H. Poliomyelitis control in Japan. Rev Infect Dis 1984; 6(Suppl 2)S427–30
- Infectious Agents Surveillance Center. Poliomyelitis, Japan, 1962–1995. Infect Agents Surveillance Rep 1997;18:1–2.
- Lago PM, Bravo JR, Andrus JK, Comellas MM, Galindo MA, Quadros CA, et al. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bulletin WHO 1994; 72: 221–5
- Ramsay M, Begg N, Gandhi J, Brown D. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. Pediatr Infect Dis J 1994; 13: 1117–21
- World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis 1995;171:1097–106.
- World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia, Oman, and Thailand. J Infect Dis 1997;175 (Suppl 1):S215–27.
- Vaccine Administration Subcommittee. Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children. Japan J Med Sci Biol 1966;19:277–91.
- Vaccine Administration Subcommittee. Evaluation of Sabin live poliovirus vaccine in Japan. III. Studies on the method of administration of Sabin vaccine for babies. Japan J Med Sci Biol 1967;20:151–66.
- World Health Organization. 2003. Global polio eradication initiative strategic plan 2004–2008.World Health Organization, Geneva.
- Kew OM, Wright P, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull WHO 2004; 82: 16–23
- Centers for Disease Control and Prevention. Update on vaccine-derived polioviruses. MMWR 2006;55:1093–7.
- World Health Organization. Weekly Epidemiological Record 2006;81:61–8.
- Matsuura K, Ishikura M, Yoshida H, Nakayama T, Hasegawa S, Ando S, et al. Assessment of poliovirus eradication in Japan: genomic analysis of the polioviruses isolated from the river water and the sewage in Toyama Prefecture. Appl Environ Microbiol 2000; 66: 5087–91
- Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS. Correlation between amount of virus with acceptability of oral poliovirus vaccine. Proc Natl Acad Sci USA 1991; 88: 199–203
- Chumakov KM, Dragunsky EM, Norwood LP, Douthitt MP, Ran Y, Taffs RE, et al. Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. J Med Virol 1994; 42: 79–85
- Horie H, Yoshida H, Matsuura K, Miyazawa M, Ota Y, Nakayama T, et al. Neurovirulence of type 1 polioviruses isolated from sewage in Japan. Appl Environ Microbiol 2002; 68: 138–42
- Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, et al. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol 2002; 68: 445–51
- Yoshida H, Horie H, Matsuura K, Kitamura T, Hashizume S, Miyamura T. Prevalence of vaccine-derived polioviruses in the environment. J Gen Virol 2002; 83: 1107–11
- Yoshida H, Horie H, Matsuura K, Miyamura T. Characterization of polioviruses isolated from sewage and river water in Japan. Lancet 2000; 356: 1461–3
- Iwai M, Nakayama T, Matsuura K, Hasegawa S, Ando S, Obara M, et al. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan. Acta Virologica 2006; 50: 139–43
- World Health Organization. Manual of laboratory methods for potency testing of vaccines used in the WHO Expanded Programme on Immunization. 1995. WHO publication no. WHO/BLG/95.1. World Health Organization, Geneva.
- Shimizu B. Poliovaccine. Rinsho to Biseibutsu 2004;31:349–53. (In Japanese.)
- Modlin FJ, Halsey NA, Thomas ML, Meschievitz CK, Patriarca PA, Baltimore Area Polio Vaccine Study Group. Humoral and mucosal immunity in infants induced by 3 sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis 1997;175 (Suppl 1):S228–34.
- Nishio O, Ishihara Y, Sakae K, Nonomura Y, Kuno A, Yasukawa S, et al. The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for 10 y. J Biol Stand 1984; 12: 1–10